Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer

Recent Results Cancer Res. 1991:121:173-81. doi: 10.1007/978-3-642-84138-5_19.

Authors

L Schmid¹, B Thürlimann, M Müller, H J Senn

Affiliation

¹ Abteilung für Onkologie und Hämatologie, Kantonsspital, St. Gallen, Switzerland.

PMID: 1857857
DOI: 10.1007/978-3-642-84138-5_19

No abstract available

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Granulocytes / drug effects
Hematologic Diseases / chemically induced
Hemoglobins / analysis
Humans
Leukocyte Count / drug effects
Male
Middle Aged
Neoplasms / therapy*
Platelet Count / drug effects
Recombinant Proteins / adverse effects
Recombinant Proteins / therapeutic use
Remission Induction

Substances

Hemoglobins
Recombinant Proteins
Granulocyte-Macrophage Colony-Stimulating Factor